Properties
Description
Laropiprant (MK0524) inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets DP, and TP receptor.
Molecular Formula
C21H19ClFNO4S
Targets
DP: 0.57 nM; TP receptor: 2.95 nM
Applications
Laropiprant (MK0524) can be used to lower cholesterol.